Phage and CRISPR based precision antimicrobials: a dual strategy against multidrug-resistant bacteria.

publication — a durable, citable reference into the African DSI DataBank's federated catalog.

Last updated 8/26/2026, 10:02:37 PM

Cite this record

African DSI DataBank. Phage and CRISPR based precision antimicrobials: a dual strategy against multidrug-resistant bacteria.. AFDSI-PUB-503. 2026. https://hub.africandsidatabank.africa/cite/AFDSI-PUB-503 Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42599326/.Copy citation

@misc{AFDSIPUB503,
  title        = {Phage and CRISPR based precision antimicrobials: a dual strategy against multidrug-resistant bacteria.},
  author       = {{African DSI DataBank}},
  year         = {2026},
  howpublished = {\url{https://hub.africandsidatabank.africa/cite/AFDSI-PUB-503}},
  note         = {African DSI DataBank citable identifier AFDSI-PUB-503; Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42599326/}
}

AFDSI-PUB-503 is a stable, resolvable local identifier — not a registered DOI. See Terms of use's "Citation policy" for the full explanation.